# G-CSF After Chemo-radiation in Patients With Glioblastoma

> **NCT06649851** · PHASE2 · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 60 (estimated)

## Conditions studied

- MGMT-Methylated Glioblastoma
- Glioblastoma (GBM)
- Newly Diagnosed Glioblastoma Multiforme

## Interventions

- **DRUG:** Granulocyte Colony Stimulating Factor (G-CSF)
- **RADIATION:** Radiation Therapy + Temozolomide

## Key facts

- **NCT ID:** NCT06649851
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-02
- **Primary completion:** 2027-01-31
- **Final completion:** 2030-01-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06649851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06649851, "G-CSF After Chemo-radiation in Patients With Glioblastoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06649851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*